Dilip Shanghvi
$25.7B
$173.8M (0.7%)
as of 06/13/26
About Dilip Shanghvi
The son of a pharmaceuticals distributor, Dilip Shanghvi borrowed $200 from his father to start Sun Pharmaceutical Industries in 1983 to make psychiatric drugs.
The company is India's most valuable listed pharma outfit and gets two-thirds of its $6.1 billion annual revenue from overseas markets.
He grew Sun through a series of acquisitions, the biggest of which was the 2014 purchase of scandal-tainted rival Ranbaxy Laboratories for $4 billion.
Sun Pharma acquired U.S. skin cancer drug maker Checkpoint Therapeutics in May 2025 for $355 million.
In February 2025, his son Aalok was appointed as chief operating officer of Sun Pharma.
Personal stats
Citizenship
IndiaSource of wealth
PharmaceuticalsResidence
Mumbai, IndiaMarital status
MarriedBirth date
10/01/55 (age 70)Number of children
2Education
Bachelor of Arts/Science, Calcutta UniversitySelf-made
self-madeDilip Shanghvi’s fortune is worth
428K
troy ounces of gold
395K
median U.S. household
257K
median U.S. income
0.514%
U.S. credit card volume
0.103%
GDP of the United States
0.076%
United States debt
Net worth history
Annual ranking
Related people
Did you know?
Photos of Shanghvi's family deity, Shrinathji, adorn Sun's factories and offices.
Net worth over time
Real-time ranking
Financial assets
BSE INDIA | 532872-IN
Sun Pharma Advanced ResearchBSE INDIA | 524715-IN
Sun Pharmaceutical Industries Ltd.BSE INDIA | 532667-IN
Suzlon Energy Ltd.Images © Forbes.com. All rights reserved.